ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Reinvestment Rate
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Reinvestment Rate of 42.29x as of December 2024, reinvesting CN¥1.21 Billion (capex CN¥286.36 Million plus investments CN¥-925.26 Million) from operating cash flow of CN¥28.65 Million. Check ChengDa Pharmaceuticals Co. Ltd. (301201) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Explore 301201 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for ChengDa Pharmaceuticals Co. Ltd.. For live market cap and broader valuation context, see ChengDa Pharmaceuticals Co. Ltd. (301201) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 42.29x | CN¥1.21 Billion | CN¥28.65 Million | CN¥286.36 Million | ▲ +678.6% |
| 2023 | 5.43x | CN¥1.04 Billion | CN¥192.07 Million | CN¥224.67 Million | ▼ -78.3% |
| 2022 | 25.06x | CN¥1.19 Billion | CN¥47.67 Million | CN¥205.69 Million | ▲ +651.3% |
| 2021 | 3.34x | CN¥277.28 Million | CN¥83.14 Million | CN¥138.70 Million | ▲ +481.4% |
| 2020 | 0.57x | CN¥73.99 Million | CN¥128.97 Million | CN¥63.81 Million | ▼ -60.8% |
| 2019 | 1.46x | CN¥98.73 Million | CN¥67.52 Million | CN¥51.06 Million | — |